ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Pfizer Inc. (PFE) stock surged +1.54%, trading at $26.30 on NYSE, up from the previous close of $25.90. The stock opened at $25.89, fluctuating between $25.85 and $26.57 in the recent session.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Employees | 88000 |
Beta | 0.57 |
Sales or Revenue | $58.50B |
5Y Sales Change% | 0.135% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Pfizer Inc. (NYSE: PFE) stock price is $26.30 in the last trading session. During the trading session, PFE stock reached the peak price of $26.57 while $25.85 was the lowest point it dropped to. The percentage change in PFE stock occurred in the recent session was 1.54% while the dollar amount for the price change in PFE stock was $0.40.
The NYSE listed PFE is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Pfizer Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Christopher J. Stevo CFA
Senior Vice President & Chief Investor Relations Officer
Mr. David M. Denton
Chief Financial Officer & Executive Vice President
Mr. Frank A. D'Amelio
Chief Financial Officer & Executive Vice President
Dr. Albert Bourla D.V.M., DVM, Ph.D.
Chairman & Chief Executive Officer
Dr. Mikael Dolsten M.D., Ph.D.
Chief Scientific Officer and Pres of Worldwide Research, Devel. & Medical
Ms. Angela Hwang
Chief Commercial Officer & Pres of Global Biopharmaceuticals Bus.
Mr. Douglas M. Lankler
Executive Vice President & Gen. Counsel
Ms. Lidia L. Fonseca
Executive Vice President and Chief Digital & Technology Officer
Mr. John D. Young
Advisor
Dr. William Pao M.D., Ph.D.
Executive Officer
Ms. Jennifer B. Damico
Senior Vice President, Controller & Principal Accounting Officer
PFE's closing price is 7.43% higher than its 52-week low of $24.48 where as its distance from 52-week high of $31.54 is -16.61%.
Number of PFE employees currently stands at 88,000.
Official Website of PFE is: https://www.pfizer.com
PFE could be contacted at phone 212 733 2323 and can also be accessed through its website. PFE operates from 235 East 42nd Street, New York, NY 10017, United States.
PFE stock volume for the day was 46.61M shares. The average number of PFE shares traded daily for last 3 months was 39.96M.
The market value of PFE currently stands at $149.04B with its latest stock price at $26.30 and 5.67B of its shares outstanding.